IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 246 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,348,181 | -9.5% | 139,998 | 0.0% | 0.03% | -3.4% |
| Q2 2023 | $1,489,579 | +5.4% | 139,998 | +4.2% | 0.03% | +7.4% |
| Q1 2023 | $1,412,752 | -13.3% | 134,292 | +2.1% | 0.03% | -15.6% |
| Q4 2022 | $1,630,401 | +22.1% | 131,590 | +2.2% | 0.03% | +18.5% |
| Q3 2022 | $1,335,000 | -7.5% | 128,753 | +3.0% | 0.03% | +3.8% |
| Q2 2022 | $1,443,000 | +19.3% | 125,050 | +30.1% | 0.03% | +44.4% |
| Q1 2022 | $1,210,000 | – | 96,148 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |